Alumna Wins Maltz Prize For Innovative & Promising Schizophrenia Research
Deanna L. Kelly, PharmD, BCPP, affiliate professor in the Department of Pharmacy Practice and Science (PPS) at the University of Maryland School of Pharmacy, has been named the 2017 recipient of the Maltz Prize for Innovative & Promising Schizophrenia Research by the Brain & Behavior Research Foundation. Established in 2005, the Maltz Prize provides $40,000 to an investigator who has undertaken innovative and promising research in schizophrenia. It is one of the most prestigious awards presented to researchers in the field of psychiatric disorders.
Kelly is the first pharmacist to be recognized by the Brain & Behavior Research Foundation for advancements in the field of schizophrenia research.
Kelly received her Doctor of Pharmacy (PharmD) from Duquesne University School of Pharmacy and completed her residency in psychiatric pharmacy at the University of Maryland School of Pharmacy under the mentorship of Raymond C. Love, PharmD, BCPP, FASHP, professor and vice chair for collaborative initiatives in PPS and director of the Mental Health Program at the School. A psychopharmacology researcher with more than 20 years in the field, Kelly has led numerous clinical trials aimed at advancing treatments for individuals diagnosed with schizophrenia and received continuous funding from the National Institutes of Health for the past 15 years.
She currently serves as a research mentor for the PGY-2 Psychiatric Pharmacy Residency Program at the School.
Kelly has authored and co-authored 16 books and book chapters, published 169 peer-reviewed articles, presented more than 140 posters, and delivered more than 135 invited lectures. She is vice chair of the Maryland Department of Health Institutional Review Board and current president of the College of Psychiatric & Neurologic Pharmacists.
"I am incredibly honored and humbled to have been named this year's recipient of the Maltz Prize for Innovative & Promising Schizophrenia Research," says Kelly. "Although we as researchers know that we cannot treat all patients the same, we also understand that we can make many different discoveries - all of which are incredibly important - but, unless we are able to experiment with them in the clinical trial design, we are never going to be able to translate those discoveries into treatments for our patients who are in need. This award represents a truly amazing opportunity for my team and reinforces our belief that the focus of our research matters."
University of Maryland News Center
Founded in 1878, Duquesne is consistently ranked among the nation's top Catholic universities for its award-winning faculty and tradition of academic excellence. Duquesne, a campus of nearly 9,500 graduate and undergraduate students, has been nationally recognized for its academic programs, community service and commitment to sustainability. Follow Duquesne University on Facebook, Twitter and Instagram.